ORDINARY SHARE PURCHASE AGREEMENTOrdinary Share Purchase Agreement • August 29th, 2025 • Akari Therapeutics PLC • Pharmaceutical preparations • New York
Contract Type FiledAugust 29th, 2025 Company Industry JurisdictionThis Ordinary Share Purchase Agreement (this “Agreement”) is entered into effective as August 29, 2025 (the “Execution Date”), by and between Akari Therapeutics, Plc, public limited company incorporated under the laws of England and Wales (the “Company”), and White Lion Capital, LLC, a Nevada limited liability company (the “Investor”).
ORDINARY SHARE PURCHASE AGREEMENTOrdinary Share Purchase Agreement • August 29th, 2025 • Akari Therapeutics PLC • Pharmaceutical preparations • New York
Contract Type FiledAugust 29th, 2025 Company Industry JurisdictionThis Ordinary Share Purchase Agreement (this “Agreement”) is entered into effective as August 29, 2025 (the “Execution Date”), by and between Akari Therapeutics, Plc, public limited company incorporated under the laws of England and Wales (the “Company”), and White Lion Capital, LLC, a Nevada limited liability company (the “Investor”).